Advertisement

Overview: The Paradox of Microbial Impact on the Immune System in Allergy Prevention and Exacerbation

  • Carsten B. Schmidt-WeberEmail author
Chapter
Part of the Birkhäuser Advances in Infectious Diseases book series (BAID)

Abstract

Allergy prevalence has been increasing to epidemic proportions. The term “allergy tsunami” was even coined after the prevalence of allergen sensitization in school-aged children jumped to more than 40%. Because of the huge economic impact on the health care system and the dramatic impact on quality of life, allergy prevention has become very relevant. In this context, it is interesting that infectious diseases are becoming less prevalent and increasingly under control, while noncommunicable diseases (including, but not limited to, allergy) increase. This also applies to autoimmune diseases, which are characterized by an overactive immune response.

The immune system’s response to antigens and the microbiome is critical for the outcome of infections and allergies. Paradoxically, the microbiome can play a protective role in allergies, but it is also known to be the driver of exacerbations. The current chapter focuses on this paradox and therefore starts with the topic of autoallergy, in which microbial antigens are considered to be potential pathogens and disease initiators. Bacterial allergens are generally thought of as potential “virulence factors” and exacerbation factors in allergy. In contrast, the allergy-protective microbiome, which was discovered in protective agricultural environments, is the second key aspect of this chapter. Additional environmental elements that were lost due to lifestyle changes are also highlighted. Both farm and lifestyle effects contributed to the hygiene hypothesis, which is challenged by the author to show that “dirt” is not at all protective against allergies. Determinants and metabolites of bacteria and molds that co-evolutionized with man have been identified in rural environments, with stunning effects on our immune systems.

Allergy prevention at least partially develops in our gut through a complex interplay of microbiota with our immune system. Here, the persistence of type-2 allergen memory, such as interleukin-4 and immunoglobulin E–producing cells, is particularly important and relevant for food allergies. This chapter also describes a recently discovered mechanism that links the gut microbiome with pro-allergic type-2 immunity. The mechanism of environmental sensing is discussed, using the example of the aryl hydrocarbon receptor to demonstrate the link between microbiota, their metabolites, and their recognition at cellular and molecular levels. For the prevention of microbiome-driven exacerbations, the chapter also discusses therapeutic options with novel diagnostics and biologics that are likely to influence the future management of allergies. (For a graphical chapter overview, see Fig. 1.)

Keywords

Allergy Prevention Bacterial Allergens Aryl Hydrocarbon Receptor (AhR) Hygiene Hypothesis Agricultural Environmental Protection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Barnes KC (2006) Genetic epidemiology of health disparities in allergy and clinical immunology. J Allergy Clin Immunol 117(2):243–254.  https://doi.org/10.1016/j.jaci.2005.11.030 CrossRefPubMedGoogle Scholar
  2. Basdeo SA, Cluxton D, Sulaimani J, Moran B, Canavan M, Orr C, Veale DJ, Fearon U, Fletcher JM (2017) Ex-Th17 (nonclassical Th1) cells are functionally distinct from classical Th1 and Th17 cells and are not constrained by regulatory T cells. J Immunol 198(6):2249–2259.  https://doi.org/10.4049/jimmunol.1600737 CrossRefPubMedGoogle Scholar
  3. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81(1):1–5.  https://doi.org/10.1189/jlb.0306164 CrossRefPubMedGoogle Scholar
  4. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB, Bonnelykke K, Brasholt M, Heltberg A, Vissing NH, Thorsen SV, Stage M, Pipper CB (2007) Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 357(15):1487–1495.  https://doi.org/10.1056/NEJMoa052632 CrossRefPubMedGoogle Scholar
  5. Campbell DE, Boyle RJ, Thornton CA, Prescott SL (2015) Mechanisms of allergic disease – environmental and genetic determinants for the development of allergy. Clin Exp Allergy 45(5):844–858.  https://doi.org/10.1111/cea.12531 CrossRefPubMedGoogle Scholar
  6. Cosmi L, Cimaz R, Maggi L, Santarlasci V, Capone M, Borriello F, Frosali F, Querci V, Simonini G, Barra G, Piccinni MP, Liotta F, De Palma R, Maggi E, Romagnani S, Annunziato F (2011) Evidence of the transient nature of the Th17 phenotype of CD4+CD161+ T cells in the synovial fluid of patients with juvenile idiopathic arthritis. Arthritis Rheum 63(8):2504–2515.  https://doi.org/10.1002/art.30332 CrossRefPubMedGoogle Scholar
  7. Du Toit G, Katz Y, Sasieni P, Mesher D, Maleki SJ, Fisher HR, Fox AT, Turcanu V, Amir T, Zadik-Mnuhin G, Cohen A, Livne I, Lack G (2008) Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy. J Allergy Clin Immunol 122(5):984–991.  https://doi.org/10.1016/j.jaci.2008.08.039 CrossRefPubMedGoogle Scholar
  8. Eyerich K, Pennino D, Scarponi C, Foerster S, Nasorri F, Behrendt H, Ring J, Traidl-Hoffmann C, Albanesi C, Cavani A (2009a) IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol 123(1):59–66.e54.  https://doi.org/10.1016/j.jaci.2008.10.031 CrossRefPubMedGoogle Scholar
  9. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, Durham SR, Schmidt-Weber CB, Cavani A (2009b) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119(12):3573–3585.  https://doi.org/10.1172/JCI40202 PubMedPubMedCentralGoogle Scholar
  10. Gelfand EW, Joetham A, Wang M, Takeda K, Schedel M (2017) Spectrum of T-lymphocyte activities regulating allergic lung inflammation. Immunol Rev 278(1):63–86.  https://doi.org/10.1111/imr.12561 CrossRefPubMedGoogle Scholar
  11. Holgate ST (1999) Genetic and environmental interaction in allergy and asthma. J. Allergy Clin Immunol 104(6):1139–1146CrossRefGoogle Scholar
  12. Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A (2009) Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann Neurol 66(3):390–402.  https://doi.org/10.1002/ana.21748 CrossRefPubMedGoogle Scholar
  13. Kleinschek MA, Boniface K, Sadekova S, Grein J, Murphy EE, Turner SP, Raskin L, Desai B, Faubion WA, de Waal Malefyt R, Pierce RH, McClanahan T, Kastelein RA (2009) Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J Exp Med 206(3):525–534.  https://doi.org/10.1084/jem.20081712 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Kraus TA, Brimnes J, Muong C, Liu JH, Moran TM, Tappenden KA, Boros P, Mayer L (2005) Induction of mucosal tolerance in Peyer’s patch-deficient, ligated small bowel loops. J Clin Invest 115(8):2234–2243.  https://doi.org/10.1172/JCI19102 CrossRefPubMedPubMedCentralGoogle Scholar
  15. Lee TH, Song HJ, Park CS (2014) Role of inflammasome activation in development and exacerbation of asthma. Asia Pac Allergy 4(4):187–196.  https://doi.org/10.5415/apallergy.2014.4.4.187 CrossRefPubMedPubMedCentralGoogle Scholar
  16. Licona-Limon P, Kim LK, Palm NW, Flavell RA (2013) TH2, allergy and group 2 innate lymphoid cells. Nat Immunol 14(6):536–542.  https://doi.org/10.1038/ni.2617 CrossRefPubMedGoogle Scholar
  17. Mantel PY, Ouaked N, Ruckert B, Karagiannidis C, Welz R, Blaser K, Schmidt-Weber CB (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176(6):3593–3602CrossRefPubMedGoogle Scholar
  18. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 107(33):14751–14756.  https://doi.org/10.1073/pnas.1003852107 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Oeser K, Maxeiner J, Symowski C, Stassen M, Voehringer D (2015) T cells are the critical source of IL-4/IL-13 in a mouse model of allergic asthma. Allergy 70(11):1440–1449.  https://doi.org/10.1111/all.12705 CrossRefPubMedGoogle Scholar
  20. Paul WE, Zhu J (2010) How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol 10(4):225–235.  https://doi.org/10.1038/nri2735 CrossRefPubMedPubMedCentralGoogle Scholar
  21. Pennino D, Bhavsar PK, Effner R, Avitabile S, Venn P, Quaranta M, Marzaioli V, Cifuentes L, Durham SR, Cavani A, Eyerich K, Chung KF, Schmidt-Weber CB, Eyerich S (2013) IL-22 suppresses IFN-gamma-mediated lung inflammation in asthmatic patients. J Allergy Clin Immunol 131(2):562–570.  https://doi.org/10.1016/j.jaci.2012.09.036 CrossRefPubMedGoogle Scholar
  22. Silkoff PE, Flavin S, Gordon R, Loza MJ, Sterk PJ, Lutter R, Diamant Z, Turner RB, Lipworth BJ, Proud D, Singh D, Eich A, Backer V, Gern JE, Herzmann C, Halperin SA, Mensinga TT, Del Vecchio AM, Branigan P, San Mateo L, Baribaud F, Barnathan ES, Johnston SL (2017) Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: a randomized controlled study. J Allergy Clin Immunol.  https://doi.org/10.1016/j.jaci.2017.06.027
  23. Suzuki H, Sekine S, Kataoka K, Pascual DW, Maddaloni M, Kobayashi R, Fujihashi K, Kozono H, McGhee JR, Fujihashi K (2008) Ovalbumin-protein sigma 1 M-cell targeting facilitates oral tolerance with reduction of antigen-specific CD4+ T cells. Gastroenterology 135(3):917–925.  https://doi.org/10.1053/j.gastro.2008.05.037 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Tripathi A, Conley DB, Grammer LC, Ditto AM, Lowery MM, Seiberling KA, Yarnold PA, Zeifer B, Kern RC (2004) Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis. Laryngoscope 114(10):1822–1826.  https://doi.org/10.1097/00005537-200410000-00027 CrossRefPubMedGoogle Scholar
  25. Van Zele T, Gevaert P, Watelet JB, Claeys G, Holtappels G, Claeys C, van Cauwenberge P, Bachert C (2004) Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 114(4):981–983.  https://doi.org/10.1016/j.jaci.2004.07.013 CrossRefPubMedGoogle Scholar
  26. Verhoef PA, Constantinides MG, McDonald BD, Urban JF Jr, Sperling AI, Bendelac A (2016) Intrinsic functional defects of type 2 innate lymphoid cells impair innate allergic inflammation in promyelocytic leukemia zinc finger (PLZF)-deficient mice. J Allergy Clin Immunol 137(2):591–600.e591.  https://doi.org/10.1016/j.jaci.2015.07.050 CrossRefPubMedGoogle Scholar
  27. Virtanen T, Zeiler T, Rautiainen J, Mantyjarvi R (1999) Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself? Immunol Today 20(9):398–400CrossRefPubMedGoogle Scholar
  28. Zissler UM, Chaker AM, Effner R, Ulrich M, Guerth F, Piontek G, Dietz K, Regn M, Knapp B, Theis FJ, Heine H, Suttner K, Schmidt-Weber CB (2016) Interleukin-4 and interferon-gamma orchestrate an epithelial polarization in the airways. Mucosal Immunol 9(4):917–926.  https://doi.org/10.1038/mi.2015.110 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Center of Allergy and Environment (ZAUM)Technical University and Helmholtz Center MunichMunichGermany

Personalised recommendations